Business Context and Reporting Period
Company: Prudential plc (PRU)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Six months ended 30 June 2026
Announcement Date: 27 August 2026
Prudential plc, a leading life and health insurer and asset manager operating across Asia and Africa, reported its half-year 2026 results. The period was characterized by disciplined execution, quality growth, and strong capital generation. The Group continued to invest in long-term growth opportunities, including increasing its stake in its Malaysia life business to 70% and agreeing to acquire a 75% stake in Bharti Life in India.
Key Financial Metrics
| Metric | Half Year 2026 ($m) | Half Year 2025 ($m) | Change (CER) |
|---|---|---|---|
| New Business Profit (NBP) | 1,384 | 1,260 | +8% |
| New Business Margin | 40% | 38% | +2 ppts |
| Operating Free Surplus Generated (Gross OFSG) | 1,791 | 1,560 | +15% |
| Adjusted Operating Profit Before Tax | 1,812 | 1,644 | +9% |
| Adjusted Operating Profit After Tax | 1,523 | 1,366 | +10% |
| Adjusted EPS | 58.4 cents | 49.3 cents | +17% |
| IFRS Profit After Tax | 995 | 1,359 | -27% |
| Group TEV Equity | $39.1 billion | $37.8 billion | +3% |
| Free Surplus Ratio | 209% | 221% | -12 ppts |
Material Changes vs. Prior Period
- Profitability Growth: Adjusted operating profit after tax grew 10% on a constant exchange rate (CER) basis, driven by higher insurance service revenue and lower central costs. New business profit grew 8% with margins expanding 2 percentage points to 40%.
- IFRS Volatility: IFRS profit after tax declined 27% to $995 million, primarily due to short-term market fluctuations of $(626) million caused by interest rate movements in the US and Asia, offsetting operating gains.
- Regional Performance:
- Hong Kong: NBP grew 8% with margin expansion to 57%, despite high prior-year comparators.
- Chinese Mainland: NBP declined 4% (CER) due to regulatory expense controls and a product mix shift toward participating products, though APE sales grew 21%.
- Malaysia: NBP surged 46% (CER) following the increase in ownership stake and improved agency productivity.
- Asset Management (Eastspring): Adjusted operating profit after tax grew 20% on a like-for-like basis, with funds under management rising 5% to $290.8 billion.
- Capital Position: The free surplus ratio decreased to 209% from 221% as the Group executed significant capital returns to shareholders.
Guidance, Outlook, and Management Commentary
- Shareholder Returns: The Group returned $1.0 billion to shareholders in the first half of 2026. The Board approved a first interim dividend of 8.88 cents per share (+15% YoY). Additionally, Prudential announced an extra circa $0.3 billion share buyback for 2026, bringing the total 2026 buyback programme to $1.5 billion.
- Strategic Investments: The Group is repositioning its India operations by acquiring a 75% stake in Bharti Life and launching a standalone health entity in Q3 2026. It also increased its stake in Malaysia to 70%.
- Outlook: Management reaffirmed its FY26 guidance for double-digit growth in new business profit, Gross OFSG, and Adjusted EPS.
- Chinese Mainland: Full-year 2026 NBP is expected to be similar to 2025 levels as the business adjusts to regulatory changes.
- Hong Kong: Underlying demand remains strong, though the business faces high comparators in July and August.
- Risks: Key risks include geopolitical tensions, regulatory changes (particularly in the Chinese Mainland and regarding health insurance affordability), interest rate volatility, and cyber security threats. The Group maintains a strong capital buffer to navigate these uncertainties.
Investor Verification Checklist
- Regulatory Impact in China: Verify the long-term impact of prescriptive bancassurance expense controls on Chinese Mainland margins and profitability.
- IFRS vs. Adjusted Profit: Reconcile the 27% decline in IFRS profit against the 10% growth in adjusted operating profit to understand the magnitude of short-term market fluctuations.
- India Acquisition: Monitor the progress of regulatory approvals for the Bharti Life acquisition and the required divestment of the ICICI Prudential Life stake.
- Capital Allocation: Confirm the completion of the additional $0.3 billion buyback and the funding source (proceeds from the ICICI Prudential Asset Management Company stake sale).
- Health Business Margins: Assess the sustainability of health and protection margins given rising medical inflation and regulatory pressure on pricing in key markets like Singapore and Indonesia.